This EBMT guideline paper examined how and when to integrate palliative and supportive care across the full continuum of haematopoietic cell transplantation (HCT) and cellular therapies (including CAR-T), covering adults and children with haematologic malignancies.
An international multidisciplinary expert panel generated consensus-based, non-graded recommendations supporting early, systematic palliative care integration to reduce symptom burden, improve quality of life, and facilitate complex decision-making across key domains: symptom management, psychological distress, GvHD, relapse, end-of-life care, advance care planning, caregiver support, health inequities, and clinician wellbeing.
Recommendations are expert-consensus based and non-graded, reflecting heterogeneous and often limited primary evidence; implementation strategies were not empirically tested, and equity-related recommendations acknowledge that access to palliative care remains uneven across health systems.
Palliative and supportive care should be integrated early and systematically—not reserved for end of life—in all patients undergoing HCT or CAR-T therapy. Use practical referral triggers and patient-reported outcomes to ensure timely, equitable access throughout treatment.